Global Active Pharmaceutical Ingredient(API) Market Growth 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
The global Active Pharmaceutical Ingredient(API) market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Active Pharmaceutical Ingredient(API) is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Active Pharmaceutical Ingredient(API) is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Active Pharmaceutical Ingredient(API) is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Active Pharmaceutical Ingredient(API) players cover Teva Pharmaceuticals, Pfizer, Aurobindo Pharma, Sun Pharmaceutical Industries Ltd., Novartis, Mylan, Boehringer Ingelheim, Merck&Co. and AbbVie, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
Active Pharmaceutical Ingredient (API) is the biologically active component of a drug product (tablet, capsule, cream, injectable) that produces the intended effects.
LPI (LP Information)' newest research report, the “Active Pharmaceutical Ingredient(API) Industry Forecast” looks at past sales and reviews total world Active Pharmaceutical Ingredient(API) sales in 2022, providing a comprehensive analysis by region and market sector of projected Active Pharmaceutical Ingredient(API) sales for 2023 through 2029. With Active Pharmaceutical Ingredient(API) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Active Pharmaceutical Ingredient(API) industry.
This Insight Report provides a comprehensive analysis of the global Active Pharmaceutical Ingredient(API) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Active Pharmaceutical Ingredient(API) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Active Pharmaceutical Ingredient(API) market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Active Pharmaceutical Ingredient(API) and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Active Pharmaceutical Ingredient(API).
This report presents a comprehensive overview, market shares, and growth opportunities of Active Pharmaceutical Ingredient(API) market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
What is the 10-year outlook for the global Active Pharmaceutical Ingredient(API) market?
What factors are driving Active Pharmaceutical Ingredient(API) market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Active Pharmaceutical Ingredient(API) market opportunities vary by end market size?
How does Active Pharmaceutical Ingredient(API) break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
The global Active Pharmaceutical Ingredient(API) market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Active Pharmaceutical Ingredient(API) is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Active Pharmaceutical Ingredient(API) is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Active Pharmaceutical Ingredient(API) is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Active Pharmaceutical Ingredient(API) players cover Teva Pharmaceuticals, Pfizer, Aurobindo Pharma, Sun Pharmaceutical Industries Ltd., Novartis, Mylan, Boehringer Ingelheim, Merck&Co. and AbbVie, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
Active Pharmaceutical Ingredient (API) is the biologically active component of a drug product (tablet, capsule, cream, injectable) that produces the intended effects.
LPI (LP Information)' newest research report, the “Active Pharmaceutical Ingredient(API) Industry Forecast” looks at past sales and reviews total world Active Pharmaceutical Ingredient(API) sales in 2022, providing a comprehensive analysis by region and market sector of projected Active Pharmaceutical Ingredient(API) sales for 2023 through 2029. With Active Pharmaceutical Ingredient(API) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Active Pharmaceutical Ingredient(API) industry.
This Insight Report provides a comprehensive analysis of the global Active Pharmaceutical Ingredient(API) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Active Pharmaceutical Ingredient(API) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Active Pharmaceutical Ingredient(API) market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Active Pharmaceutical Ingredient(API) and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Active Pharmaceutical Ingredient(API).
This report presents a comprehensive overview, market shares, and growth opportunities of Active Pharmaceutical Ingredient(API) market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
- Generic API
- Innovative API
- Oncology
- Cardiology
- Cns and Neurology
- Orthopaedic
- Pulmonology
- Gastroenterology
- Nephrology
- Ophthalmology
- Endocrinology
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Teva Pharmaceuticals
- Pfizer
- Aurobindo Pharma
- Sun Pharmaceutical Industries Ltd.
- Novartis
- Mylan
- Boehringer Ingelheim
- Merck&Co.
- AbbVie
- Biocon
- Bristol Myers Squibb
- C.H.Boehringer Sohn AG&Co.KG
- Cipla
- Albemarle Corporation
- Viatris
- Dr. Reddy's Laboratories
What is the 10-year outlook for the global Active Pharmaceutical Ingredient(API) market?
What factors are driving Active Pharmaceutical Ingredient(API) market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Active Pharmaceutical Ingredient(API) market opportunities vary by end market size?
How does Active Pharmaceutical Ingredient(API) break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Active Pharmaceutical Ingredient(API) Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Active Pharmaceutical Ingredient(API) by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Active Pharmaceutical Ingredient(API) by Country/Region, 2018, 2022 & 2029
2.2 Active Pharmaceutical Ingredient(API) Segment by Type
2.2.1 Generic API
2.2.2 Innovative API
2.3 Active Pharmaceutical Ingredient(API) Sales by Type
2.3.1 Global Active Pharmaceutical Ingredient(API) Sales Market Share by Type (2018-2023)
2.3.2 Global Active Pharmaceutical Ingredient(API) Revenue and Market Share by Type (2018-2023)
2.3.3 Global Active Pharmaceutical Ingredient(API) Sale Price by Type (2018-2023)
2.4 Active Pharmaceutical Ingredient(API) Segment by Application
2.4.1 Oncology
2.4.2 Cardiology
2.4.3 Cns and Neurology
2.4.4 Orthopaedic
2.4.5 Pulmonology
2.4.6 Gastroenterology
2.4.7 Nephrology
2.4.8 Ophthalmology
2.4.9 Endocrinology
2.5 Active Pharmaceutical Ingredient(API) Sales by Application
2.5.1 Global Active Pharmaceutical Ingredient(API) Sale Market Share by Application (2018-2023)
2.5.2 Global Active Pharmaceutical Ingredient(API) Revenue and Market Share by Application (2018-2023)
2.5.3 Global Active Pharmaceutical Ingredient(API) Sale Price by Application (2018-2023)
3 GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT(API) BY COMPANY
3.1 Global Active Pharmaceutical Ingredient(API) Breakdown Data by Company
3.1.1 Global Active Pharmaceutical Ingredient(API) Annual Sales by Company (2018-2023)
3.1.2 Global Active Pharmaceutical Ingredient(API) Sales Market Share by Company (2018-2023)
3.2 Global Active Pharmaceutical Ingredient(API) Annual Revenue by Company (2018-2023)
3.2.1 Global Active Pharmaceutical Ingredient(API) Revenue by Company (2018-2023)
3.2.2 Global Active Pharmaceutical Ingredient(API) Revenue Market Share by Company (2018-2023)
3.3 Global Active Pharmaceutical Ingredient(API) Sale Price by Company
3.4 Key Manufacturers Active Pharmaceutical Ingredient(API) Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Active Pharmaceutical Ingredient(API) Product Location Distribution
3.4.2 Players Active Pharmaceutical Ingredient(API) Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR ACTIVE PHARMACEUTICAL INGREDIENT(API) BY GEOGRAPHIC REGION
4.1 World Historic Active Pharmaceutical Ingredient(API) Market Size by Geographic Region (2018-2023)
4.1.1 Global Active Pharmaceutical Ingredient(API) Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Active Pharmaceutical Ingredient(API) Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Active Pharmaceutical Ingredient(API) Market Size by Country/Region (2018-2023)
4.2.1 Global Active Pharmaceutical Ingredient(API) Annual Sales by Country/Region (2018-2023)
4.2.2 Global Active Pharmaceutical Ingredient(API) Annual Revenue by Country/Region (2018-2023)
4.3 Americas Active Pharmaceutical Ingredient(API) Sales Growth
4.4 APAC Active Pharmaceutical Ingredient(API) Sales Growth
4.5 Europe Active Pharmaceutical Ingredient(API) Sales Growth
4.6 Middle East & Africa Active Pharmaceutical Ingredient(API) Sales Growth
5 AMERICAS
5.1 Americas Active Pharmaceutical Ingredient(API) Sales by Country
5.1.1 Americas Active Pharmaceutical Ingredient(API) Sales by Country (2018-2023)
5.1.2 Americas Active Pharmaceutical Ingredient(API) Revenue by Country (2018-2023)
5.2 Americas Active Pharmaceutical Ingredient(API) Sales by Type
5.3 Americas Active Pharmaceutical Ingredient(API) Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Active Pharmaceutical Ingredient(API) Sales by Region
6.1.1 APAC Active Pharmaceutical Ingredient(API) Sales by Region (2018-2023)
6.1.2 APAC Active Pharmaceutical Ingredient(API) Revenue by Region (2018-2023)
6.2 APAC Active Pharmaceutical Ingredient(API) Sales by Type
6.3 APAC Active Pharmaceutical Ingredient(API) Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Active Pharmaceutical Ingredient(API) by Country
7.1.1 Europe Active Pharmaceutical Ingredient(API) Sales by Country (2018-2023)
7.1.2 Europe Active Pharmaceutical Ingredient(API) Revenue by Country (2018-2023)
7.2 Europe Active Pharmaceutical Ingredient(API) Sales by Type
7.3 Europe Active Pharmaceutical Ingredient(API) Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Active Pharmaceutical Ingredient(API) by Country
8.1.1 Middle East & Africa Active Pharmaceutical Ingredient(API) Sales by Country (2018-2023)
8.1.2 Middle East & Africa Active Pharmaceutical Ingredient(API) Revenue by Country (2018-2023)
8.2 Middle East & Africa Active Pharmaceutical Ingredient(API) Sales by Type
8.3 Middle East & Africa Active Pharmaceutical Ingredient(API) Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Active Pharmaceutical Ingredient(API)
10.3 Manufacturing Process Analysis of Active Pharmaceutical Ingredient(API)
10.4 Industry Chain Structure of Active Pharmaceutical Ingredient(API)
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Active Pharmaceutical Ingredient(API) Distributors
11.3 Active Pharmaceutical Ingredient(API) Customer
12 WORLD FORECAST REVIEW FOR ACTIVE PHARMACEUTICAL INGREDIENT(API) BY GEOGRAPHIC REGION
12.1 Global Active Pharmaceutical Ingredient(API) Market Size Forecast by Region
12.1.1 Global Active Pharmaceutical Ingredient(API) Forecast by Region (2024-2029)
12.1.2 Global Active Pharmaceutical Ingredient(API) Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Active Pharmaceutical Ingredient(API) Forecast by Type
12.7 Global Active Pharmaceutical Ingredient(API) Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Teva Pharmaceuticals
13.1.1 Teva Pharmaceuticals Company Information
13.1.2 Teva Pharmaceuticals Active Pharmaceutical Ingredient(API) Product Portfolios and Specifications
13.1.3 Teva Pharmaceuticals Active Pharmaceutical Ingredient(API) Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Teva Pharmaceuticals Main Business Overview
13.1.5 Teva Pharmaceuticals Latest Developments
13.2 Pfizer
13.2.1 Pfizer Company Information
13.2.2 Pfizer Active Pharmaceutical Ingredient(API) Product Portfolios and Specifications
13.2.3 Pfizer Active Pharmaceutical Ingredient(API) Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Pfizer Main Business Overview
13.2.5 Pfizer Latest Developments
13.3 Aurobindo Pharma
13.3.1 Aurobindo Pharma Company Information
13.3.2 Aurobindo Pharma Active Pharmaceutical Ingredient(API) Product Portfolios and Specifications
13.3.3 Aurobindo Pharma Active Pharmaceutical Ingredient(API) Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Aurobindo Pharma Main Business Overview
13.3.5 Aurobindo Pharma Latest Developments
13.4 Sun Pharmaceutical Industries Ltd.
13.4.1 Sun Pharmaceutical Industries Ltd. Company Information
13.4.2 Sun Pharmaceutical Industries Ltd. Active Pharmaceutical Ingredient(API) Product Portfolios and Specifications
13.4.3 Sun Pharmaceutical Industries Ltd. Active Pharmaceutical Ingredient(API) Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Sun Pharmaceutical Industries Ltd. Main Business Overview
13.4.5 Sun Pharmaceutical Industries Ltd. Latest Developments
13.5 Novartis
13.5.1 Novartis Company Information
13.5.2 Novartis Active Pharmaceutical Ingredient(API) Product Portfolios and Specifications
13.5.3 Novartis Active Pharmaceutical Ingredient(API) Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Novartis Main Business Overview
13.5.5 Novartis Latest Developments
13.6 Mylan
13.6.1 Mylan Company Information
13.6.2 Mylan Active Pharmaceutical Ingredient(API) Product Portfolios and Specifications
13.6.3 Mylan Active Pharmaceutical Ingredient(API) Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Mylan Main Business Overview
13.6.5 Mylan Latest Developments
13.7 Boehringer Ingelheim
13.7.1 Boehringer Ingelheim Company Information
13.7.2 Boehringer Ingelheim Active Pharmaceutical Ingredient(API) Product Portfolios and Specifications
13.7.3 Boehringer Ingelheim Active Pharmaceutical Ingredient(API) Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Boehringer Ingelheim Main Business Overview
13.7.5 Boehringer Ingelheim Latest Developments
13.8 Merck&Co.
13.8.1 Merck&Co. Company Information
13.8.2 Merck&Co. Active Pharmaceutical Ingredient(API) Product Portfolios and Specifications
13.8.3 Merck&Co. Active Pharmaceutical Ingredient(API) Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Merck&Co. Main Business Overview
13.8.5 Merck&Co. Latest Developments
13.9 AbbVie
13.9.1 AbbVie Company Information
13.9.2 AbbVie Active Pharmaceutical Ingredient(API) Product Portfolios and Specifications
13.9.3 AbbVie Active Pharmaceutical Ingredient(API) Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 AbbVie Main Business Overview
13.9.5 AbbVie Latest Developments
13.10 Biocon
13.10.1 Biocon Company Information
13.10.2 Biocon Active Pharmaceutical Ingredient(API) Product Portfolios and Specifications
13.10.3 Biocon Active Pharmaceutical Ingredient(API) Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Biocon Main Business Overview
13.10.5 Biocon Latest Developments
13.11 Bristol Myers Squibb
13.11.1 Bristol Myers Squibb Company Information
13.11.2 Bristol Myers Squibb Active Pharmaceutical Ingredient(API) Product Portfolios and Specifications
13.11.3 Bristol Myers Squibb Active Pharmaceutical Ingredient(API) Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Bristol Myers Squibb Main Business Overview
13.11.5 Bristol Myers Squibb Latest Developments
13.12 C.H.Boehringer Sohn AG&Co.KG
13.12.1 C.H.Boehringer Sohn AG&Co.KG Company Information
13.12.2 C.H.Boehringer Sohn AG&Co.KG Active Pharmaceutical Ingredient(API) Product Portfolios and Specifications
13.12.3 C.H.Boehringer Sohn AG&Co.KG Active Pharmaceutical Ingredient(API) Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 C.H.Boehringer Sohn AG&Co.KG Main Business Overview
13.12.5 C.H.Boehringer Sohn AG&Co.KG Latest Developments
13.13 Cipla
13.13.1 Cipla Company Information
13.13.2 Cipla Active Pharmaceutical Ingredient(API) Product Portfolios and Specifications
13.13.3 Cipla Active Pharmaceutical Ingredient(API) Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Cipla Main Business Overview
13.13.5 Cipla Latest Developments
13.14 Albemarle Corporation
13.14.1 Albemarle Corporation Company Information
13.14.2 Albemarle Corporation Active Pharmaceutical Ingredient(API) Product Portfolios and Specifications
13.14.3 Albemarle Corporation Active Pharmaceutical Ingredient(API) Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Albemarle Corporation Main Business Overview
13.14.5 Albemarle Corporation Latest Developments
13.15 Viatris
13.15.1 Viatris Company Information
13.15.2 Viatris Active Pharmaceutical Ingredient(API) Product Portfolios and Specifications
13.15.3 Viatris Active Pharmaceutical Ingredient(API) Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 Viatris Main Business Overview
13.15.5 Viatris Latest Developments
13.16 Dr. Reddy's Laboratories
13.16.1 Dr. Reddy's Laboratories Company Information
13.16.2 Dr. Reddy's Laboratories Active Pharmaceutical Ingredient(API) Product Portfolios and Specifications
13.16.3 Dr. Reddy's Laboratories Active Pharmaceutical Ingredient(API) Sales, Revenue, Price and Gross Margin (2018-2023)
13.16.4 Dr. Reddy's Laboratories Main Business Overview
13.16.5 Dr. Reddy's Laboratories Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Active Pharmaceutical Ingredient(API) Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Active Pharmaceutical Ingredient(API) by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Active Pharmaceutical Ingredient(API) by Country/Region, 2018, 2022 & 2029
2.2 Active Pharmaceutical Ingredient(API) Segment by Type
2.2.1 Generic API
2.2.2 Innovative API
2.3 Active Pharmaceutical Ingredient(API) Sales by Type
2.3.1 Global Active Pharmaceutical Ingredient(API) Sales Market Share by Type (2018-2023)
2.3.2 Global Active Pharmaceutical Ingredient(API) Revenue and Market Share by Type (2018-2023)
2.3.3 Global Active Pharmaceutical Ingredient(API) Sale Price by Type (2018-2023)
2.4 Active Pharmaceutical Ingredient(API) Segment by Application
2.4.1 Oncology
2.4.2 Cardiology
2.4.3 Cns and Neurology
2.4.4 Orthopaedic
2.4.5 Pulmonology
2.4.6 Gastroenterology
2.4.7 Nephrology
2.4.8 Ophthalmology
2.4.9 Endocrinology
2.5 Active Pharmaceutical Ingredient(API) Sales by Application
2.5.1 Global Active Pharmaceutical Ingredient(API) Sale Market Share by Application (2018-2023)
2.5.2 Global Active Pharmaceutical Ingredient(API) Revenue and Market Share by Application (2018-2023)
2.5.3 Global Active Pharmaceutical Ingredient(API) Sale Price by Application (2018-2023)
3 GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT(API) BY COMPANY
3.1 Global Active Pharmaceutical Ingredient(API) Breakdown Data by Company
3.1.1 Global Active Pharmaceutical Ingredient(API) Annual Sales by Company (2018-2023)
3.1.2 Global Active Pharmaceutical Ingredient(API) Sales Market Share by Company (2018-2023)
3.2 Global Active Pharmaceutical Ingredient(API) Annual Revenue by Company (2018-2023)
3.2.1 Global Active Pharmaceutical Ingredient(API) Revenue by Company (2018-2023)
3.2.2 Global Active Pharmaceutical Ingredient(API) Revenue Market Share by Company (2018-2023)
3.3 Global Active Pharmaceutical Ingredient(API) Sale Price by Company
3.4 Key Manufacturers Active Pharmaceutical Ingredient(API) Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Active Pharmaceutical Ingredient(API) Product Location Distribution
3.4.2 Players Active Pharmaceutical Ingredient(API) Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR ACTIVE PHARMACEUTICAL INGREDIENT(API) BY GEOGRAPHIC REGION
4.1 World Historic Active Pharmaceutical Ingredient(API) Market Size by Geographic Region (2018-2023)
4.1.1 Global Active Pharmaceutical Ingredient(API) Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Active Pharmaceutical Ingredient(API) Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Active Pharmaceutical Ingredient(API) Market Size by Country/Region (2018-2023)
4.2.1 Global Active Pharmaceutical Ingredient(API) Annual Sales by Country/Region (2018-2023)
4.2.2 Global Active Pharmaceutical Ingredient(API) Annual Revenue by Country/Region (2018-2023)
4.3 Americas Active Pharmaceutical Ingredient(API) Sales Growth
4.4 APAC Active Pharmaceutical Ingredient(API) Sales Growth
4.5 Europe Active Pharmaceutical Ingredient(API) Sales Growth
4.6 Middle East & Africa Active Pharmaceutical Ingredient(API) Sales Growth
5 AMERICAS
5.1 Americas Active Pharmaceutical Ingredient(API) Sales by Country
5.1.1 Americas Active Pharmaceutical Ingredient(API) Sales by Country (2018-2023)
5.1.2 Americas Active Pharmaceutical Ingredient(API) Revenue by Country (2018-2023)
5.2 Americas Active Pharmaceutical Ingredient(API) Sales by Type
5.3 Americas Active Pharmaceutical Ingredient(API) Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Active Pharmaceutical Ingredient(API) Sales by Region
6.1.1 APAC Active Pharmaceutical Ingredient(API) Sales by Region (2018-2023)
6.1.2 APAC Active Pharmaceutical Ingredient(API) Revenue by Region (2018-2023)
6.2 APAC Active Pharmaceutical Ingredient(API) Sales by Type
6.3 APAC Active Pharmaceutical Ingredient(API) Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Active Pharmaceutical Ingredient(API) by Country
7.1.1 Europe Active Pharmaceutical Ingredient(API) Sales by Country (2018-2023)
7.1.2 Europe Active Pharmaceutical Ingredient(API) Revenue by Country (2018-2023)
7.2 Europe Active Pharmaceutical Ingredient(API) Sales by Type
7.3 Europe Active Pharmaceutical Ingredient(API) Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Active Pharmaceutical Ingredient(API) by Country
8.1.1 Middle East & Africa Active Pharmaceutical Ingredient(API) Sales by Country (2018-2023)
8.1.2 Middle East & Africa Active Pharmaceutical Ingredient(API) Revenue by Country (2018-2023)
8.2 Middle East & Africa Active Pharmaceutical Ingredient(API) Sales by Type
8.3 Middle East & Africa Active Pharmaceutical Ingredient(API) Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Active Pharmaceutical Ingredient(API)
10.3 Manufacturing Process Analysis of Active Pharmaceutical Ingredient(API)
10.4 Industry Chain Structure of Active Pharmaceutical Ingredient(API)
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Active Pharmaceutical Ingredient(API) Distributors
11.3 Active Pharmaceutical Ingredient(API) Customer
12 WORLD FORECAST REVIEW FOR ACTIVE PHARMACEUTICAL INGREDIENT(API) BY GEOGRAPHIC REGION
12.1 Global Active Pharmaceutical Ingredient(API) Market Size Forecast by Region
12.1.1 Global Active Pharmaceutical Ingredient(API) Forecast by Region (2024-2029)
12.1.2 Global Active Pharmaceutical Ingredient(API) Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Active Pharmaceutical Ingredient(API) Forecast by Type
12.7 Global Active Pharmaceutical Ingredient(API) Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Teva Pharmaceuticals
13.1.1 Teva Pharmaceuticals Company Information
13.1.2 Teva Pharmaceuticals Active Pharmaceutical Ingredient(API) Product Portfolios and Specifications
13.1.3 Teva Pharmaceuticals Active Pharmaceutical Ingredient(API) Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Teva Pharmaceuticals Main Business Overview
13.1.5 Teva Pharmaceuticals Latest Developments
13.2 Pfizer
13.2.1 Pfizer Company Information
13.2.2 Pfizer Active Pharmaceutical Ingredient(API) Product Portfolios and Specifications
13.2.3 Pfizer Active Pharmaceutical Ingredient(API) Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Pfizer Main Business Overview
13.2.5 Pfizer Latest Developments
13.3 Aurobindo Pharma
13.3.1 Aurobindo Pharma Company Information
13.3.2 Aurobindo Pharma Active Pharmaceutical Ingredient(API) Product Portfolios and Specifications
13.3.3 Aurobindo Pharma Active Pharmaceutical Ingredient(API) Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Aurobindo Pharma Main Business Overview
13.3.5 Aurobindo Pharma Latest Developments
13.4 Sun Pharmaceutical Industries Ltd.
13.4.1 Sun Pharmaceutical Industries Ltd. Company Information
13.4.2 Sun Pharmaceutical Industries Ltd. Active Pharmaceutical Ingredient(API) Product Portfolios and Specifications
13.4.3 Sun Pharmaceutical Industries Ltd. Active Pharmaceutical Ingredient(API) Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Sun Pharmaceutical Industries Ltd. Main Business Overview
13.4.5 Sun Pharmaceutical Industries Ltd. Latest Developments
13.5 Novartis
13.5.1 Novartis Company Information
13.5.2 Novartis Active Pharmaceutical Ingredient(API) Product Portfolios and Specifications
13.5.3 Novartis Active Pharmaceutical Ingredient(API) Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Novartis Main Business Overview
13.5.5 Novartis Latest Developments
13.6 Mylan
13.6.1 Mylan Company Information
13.6.2 Mylan Active Pharmaceutical Ingredient(API) Product Portfolios and Specifications
13.6.3 Mylan Active Pharmaceutical Ingredient(API) Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Mylan Main Business Overview
13.6.5 Mylan Latest Developments
13.7 Boehringer Ingelheim
13.7.1 Boehringer Ingelheim Company Information
13.7.2 Boehringer Ingelheim Active Pharmaceutical Ingredient(API) Product Portfolios and Specifications
13.7.3 Boehringer Ingelheim Active Pharmaceutical Ingredient(API) Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Boehringer Ingelheim Main Business Overview
13.7.5 Boehringer Ingelheim Latest Developments
13.8 Merck&Co.
13.8.1 Merck&Co. Company Information
13.8.2 Merck&Co. Active Pharmaceutical Ingredient(API) Product Portfolios and Specifications
13.8.3 Merck&Co. Active Pharmaceutical Ingredient(API) Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Merck&Co. Main Business Overview
13.8.5 Merck&Co. Latest Developments
13.9 AbbVie
13.9.1 AbbVie Company Information
13.9.2 AbbVie Active Pharmaceutical Ingredient(API) Product Portfolios and Specifications
13.9.3 AbbVie Active Pharmaceutical Ingredient(API) Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 AbbVie Main Business Overview
13.9.5 AbbVie Latest Developments
13.10 Biocon
13.10.1 Biocon Company Information
13.10.2 Biocon Active Pharmaceutical Ingredient(API) Product Portfolios and Specifications
13.10.3 Biocon Active Pharmaceutical Ingredient(API) Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Biocon Main Business Overview
13.10.5 Biocon Latest Developments
13.11 Bristol Myers Squibb
13.11.1 Bristol Myers Squibb Company Information
13.11.2 Bristol Myers Squibb Active Pharmaceutical Ingredient(API) Product Portfolios and Specifications
13.11.3 Bristol Myers Squibb Active Pharmaceutical Ingredient(API) Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Bristol Myers Squibb Main Business Overview
13.11.5 Bristol Myers Squibb Latest Developments
13.12 C.H.Boehringer Sohn AG&Co.KG
13.12.1 C.H.Boehringer Sohn AG&Co.KG Company Information
13.12.2 C.H.Boehringer Sohn AG&Co.KG Active Pharmaceutical Ingredient(API) Product Portfolios and Specifications
13.12.3 C.H.Boehringer Sohn AG&Co.KG Active Pharmaceutical Ingredient(API) Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 C.H.Boehringer Sohn AG&Co.KG Main Business Overview
13.12.5 C.H.Boehringer Sohn AG&Co.KG Latest Developments
13.13 Cipla
13.13.1 Cipla Company Information
13.13.2 Cipla Active Pharmaceutical Ingredient(API) Product Portfolios and Specifications
13.13.3 Cipla Active Pharmaceutical Ingredient(API) Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Cipla Main Business Overview
13.13.5 Cipla Latest Developments
13.14 Albemarle Corporation
13.14.1 Albemarle Corporation Company Information
13.14.2 Albemarle Corporation Active Pharmaceutical Ingredient(API) Product Portfolios and Specifications
13.14.3 Albemarle Corporation Active Pharmaceutical Ingredient(API) Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Albemarle Corporation Main Business Overview
13.14.5 Albemarle Corporation Latest Developments
13.15 Viatris
13.15.1 Viatris Company Information
13.15.2 Viatris Active Pharmaceutical Ingredient(API) Product Portfolios and Specifications
13.15.3 Viatris Active Pharmaceutical Ingredient(API) Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 Viatris Main Business Overview
13.15.5 Viatris Latest Developments
13.16 Dr. Reddy's Laboratories
13.16.1 Dr. Reddy's Laboratories Company Information
13.16.2 Dr. Reddy's Laboratories Active Pharmaceutical Ingredient(API) Product Portfolios and Specifications
13.16.3 Dr. Reddy's Laboratories Active Pharmaceutical Ingredient(API) Sales, Revenue, Price and Gross Margin (2018-2023)
13.16.4 Dr. Reddy's Laboratories Main Business Overview
13.16.5 Dr. Reddy's Laboratories Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Active Pharmaceutical Ingredient(API) Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Active Pharmaceutical Ingredient(API) Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Generic API
Table 4. Major Players of Innovative API
Table 5. Global Active Pharmaceutical Ingredient(API) Sales by Type (2018-2023) & (K Units)
Table 6. Global Active Pharmaceutical Ingredient(API) Sales Market Share by Type (2018-2023)
Table 7. Global Active Pharmaceutical Ingredient(API) Revenue by Type (2018-2023) & ($ million)
Table 8. Global Active Pharmaceutical Ingredient(API) Revenue Market Share by Type (2018-2023)
Table 9. Global Active Pharmaceutical Ingredient(API) Sale Price by Type (2018-2023) & (US$/Unit)
Table 10. Global Active Pharmaceutical Ingredient(API) Sales by Application (2018-2023) & (K Units)
Table 11. Global Active Pharmaceutical Ingredient(API) Sales Market Share by Application (2018-2023)
Table 12. Global Active Pharmaceutical Ingredient(API) Revenue by Application (2018-2023)
Table 13. Global Active Pharmaceutical Ingredient(API) Revenue Market Share by Application (2018-2023)
Table 14. Global Active Pharmaceutical Ingredient(API) Sale Price by Application (2018-2023) & (US$/Unit)
Table 15. Global Active Pharmaceutical Ingredient(API) Sales by Company (2018-2023) & (K Units)
Table 16. Global Active Pharmaceutical Ingredient(API) Sales Market Share by Company (2018-2023)
Table 17. Global Active Pharmaceutical Ingredient(API) Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Active Pharmaceutical Ingredient(API) Revenue Market Share by Company (2018-2023)
Table 19. Global Active Pharmaceutical Ingredient(API) Sale Price by Company (2018-2023) & (US$/Unit)
Table 20. Key Manufacturers Active Pharmaceutical Ingredient(API) Producing Area Distribution and Sales Area
Table 21. Players Active Pharmaceutical Ingredient(API) Products Offered
Table 22. Active Pharmaceutical Ingredient(API) Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Active Pharmaceutical Ingredient(API) Sales by Geographic Region (2018-2023) & (K Units)
Table 26. Global Active Pharmaceutical Ingredient(API) Sales Market Share Geographic Region (2018-2023)
Table 27. Global Active Pharmaceutical Ingredient(API) Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Active Pharmaceutical Ingredient(API) Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Active Pharmaceutical Ingredient(API) Sales by Country/Region (2018-2023) & (K Units)
Table 30. Global Active Pharmaceutical Ingredient(API) Sales Market Share by Country/Region (2018-2023)
Table 31. Global Active Pharmaceutical Ingredient(API) Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Active Pharmaceutical Ingredient(API) Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Active Pharmaceutical Ingredient(API) Sales by Country (2018-2023) & (K Units)
Table 34. Americas Active Pharmaceutical Ingredient(API) Sales Market Share by Country (2018-2023)
Table 35. Americas Active Pharmaceutical Ingredient(API) Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Active Pharmaceutical Ingredient(API) Revenue Market Share by Country (2018-2023)
Table 37. Americas Active Pharmaceutical Ingredient(API) Sales by Type (2018-2023) & (K Units)
Table 38. Americas Active Pharmaceutical Ingredient(API) Sales by Application (2018-2023) & (K Units)
Table 39. APAC Active Pharmaceutical Ingredient(API) Sales by Region (2018-2023) & (K Units)
Table 40. APAC Active Pharmaceutical Ingredient(API) Sales Market Share by Region (2018-2023)
Table 41. APAC Active Pharmaceutical Ingredient(API) Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Active Pharmaceutical Ingredient(API) Revenue Market Share by Region (2018-2023)
Table 43. APAC Active Pharmaceutical Ingredient(API) Sales by Type (2018-2023) & (K Units)
Table 44. APAC Active Pharmaceutical Ingredient(API) Sales by Application (2018-2023) & (K Units)
Table 45. Europe Active Pharmaceutical Ingredient(API) Sales by Country (2018-2023) & (K Units)
Table 46. Europe Active Pharmaceutical Ingredient(API) Sales Market Share by Country (2018-2023)
Table 47. Europe Active Pharmaceutical Ingredient(API) Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Active Pharmaceutical Ingredient(API) Revenue Market Share by Country (2018-2023)
Table 49. Europe Active Pharmaceutical Ingredient(API) Sales by Type (2018-2023) & (K Units)
Table 50. Europe Active Pharmaceutical Ingredient(API) Sales by Application (2018-2023) & (K Units)
Table 51. Middle East & Africa Active Pharmaceutical Ingredient(API) Sales by Country (2018-2023) & (K Units)
Table 52. Middle East & Africa Active Pharmaceutical Ingredient(API) Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Active Pharmaceutical Ingredient(API) Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Active Pharmaceutical Ingredient(API) Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Active Pharmaceutical Ingredient(API) Sales by Type (2018-2023) & (K Units)
Table 56. Middle East & Africa Active Pharmaceutical Ingredient(API) Sales by Application (2018-2023) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Active Pharmaceutical Ingredient(API)
Table 58. Key Market Challenges & Risks of Active Pharmaceutical Ingredient(API)
Table 59. Key Industry Trends of Active Pharmaceutical Ingredient(API)
Table 60. Active Pharmaceutical Ingredient(API) Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Active Pharmaceutical Ingredient(API) Distributors List
Table 63. Active Pharmaceutical Ingredient(API) Customer List
Table 64. Global Active Pharmaceutical Ingredient(API) Sales Forecast by Region (2024-2029) & (K Units)
Table 65. Global Active Pharmaceutical Ingredient(API) Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Active Pharmaceutical Ingredient(API) Sales Forecast by Country (2024-2029) & (K Units)
Table 67. Americas Active Pharmaceutical Ingredient(API) Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Active Pharmaceutical Ingredient(API) Sales Forecast by Region (2024-2029) & (K Units)
Table 69. APAC Active Pharmaceutical Ingredient(API) Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Active Pharmaceutical Ingredient(API) Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Europe Active Pharmaceutical Ingredient(API) Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Active Pharmaceutical Ingredient(API) Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Middle East & Africa Active Pharmaceutical Ingredient(API) Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Active Pharmaceutical Ingredient(API) Sales Forecast by Type (2024-2029) & (K Units)
Table 75. Global Active Pharmaceutical Ingredient(API) Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Active Pharmaceutical Ingredient(API) Sales Forecast by Application (2024-2029) & (K Units)
Table 77. Global Active Pharmaceutical Ingredient(API) Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Teva Pharmaceuticals Basic Information, Active Pharmaceutical Ingredient(API) Manufacturing Base, Sales Area and Its Competitors
Table 79. Teva Pharmaceuticals Active Pharmaceutical Ingredient(API) Product Portfolios and Specifications
Table 80. Teva Pharmaceuticals Active Pharmaceutical Ingredient(API) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 81. Teva Pharmaceuticals Main Business
Table 82. Teva Pharmaceuticals Latest Developments
Table 83. Pfizer Basic Information, Active Pharmaceutical Ingredient(API) Manufacturing Base, Sales Area and Its Competitors
Table 84. Pfizer Active Pharmaceutical Ingredient(API) Product Portfolios and Specifications
Table 85. Pfizer Active Pharmaceutical Ingredient(API) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 86. Pfizer Main Business
Table 87. Pfizer Latest Developments
Table 88. Aurobindo Pharma Basic Information, Active Pharmaceutical Ingredient(API) Manufacturing Base, Sales Area and Its Competitors
Table 89. Aurobindo Pharma Active Pharmaceutical Ingredient(API) Product Portfolios and Specifications
Table 90. Aurobindo Pharma Active Pharmaceutical Ingredient(API) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 91. Aurobindo Pharma Main Business
Table 92. Aurobindo Pharma Latest Developments
Table 93. Sun Pharmaceutical Industries Ltd. Basic Information, Active Pharmaceutical Ingredient(API) Manufacturing Base, Sales Area and Its Competitors
Table 94. Sun Pharmaceutical Industries Ltd. Active Pharmaceutical Ingredient(API) Product Portfolios and Specifications
Table 95. Sun Pharmaceutical Industries Ltd. Active Pharmaceutical Ingredient(API) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 96. Sun Pharmaceutical Industries Ltd. Main Business
Table 97. Sun Pharmaceutical Industries Ltd. Latest Developments
Table 98. Novartis Basic Information, Active Pharmaceutical Ingredient(API) Manufacturing Base, Sales Area and Its Competitors
Table 99. Novartis Active Pharmaceutical Ingredient(API) Product Portfolios and Specifications
Table 100. Novartis Active Pharmaceutical Ingredient(API) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 101. Novartis Main Business
Table 102. Novartis Latest Developments
Table 103. Mylan Basic Information, Active Pharmaceutical Ingredient(API) Manufacturing Base, Sales Area and Its Competitors
Table 104. Mylan Active Pharmaceutical Ingredient(API) Product Portfolios and Specifications
Table 105. Mylan Active Pharmaceutical Ingredient(API) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 106. Mylan Main Business
Table 107. Mylan Latest Developments
Table 108. Boehringer Ingelheim Basic Information, Active Pharmaceutical Ingredient(API) Manufacturing Base, Sales Area and Its Competitors
Table 109. Boehringer Ingelheim Active Pharmaceutical Ingredient(API) Product Portfolios and Specifications
Table 110. Boehringer Ingelheim Active Pharmaceutical Ingredient(API) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 111. Boehringer Ingelheim Main Business
Table 112. Boehringer Ingelheim Latest Developments
Table 113. Merck&Co. Basic Information, Active Pharmaceutical Ingredient(API) Manufacturing Base, Sales Area and Its Competitors
Table 114. Merck&Co. Active Pharmaceutical Ingredient(API) Product Portfolios and Specifications
Table 115. Merck&Co. Active Pharmaceutical Ingredient(API) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 116. Merck&Co. Main Business
Table 117. Merck&Co. Latest Developments
Table 118. AbbVie Basic Information, Active Pharmaceutical Ingredient(API) Manufacturing Base, Sales Area and Its Competitors
Table 119. AbbVie Active Pharmaceutical Ingredient(API) Product Portfolios and Specifications
Table 120. AbbVie Active Pharmaceutical Ingredient(API) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 121. AbbVie Main Business
Table 122. AbbVie Latest Developments
Table 123. Biocon Basic Information, Active Pharmaceutical Ingredient(API) Manufacturing Base, Sales Area and Its Competitors
Table 124. Biocon Active Pharmaceutical Ingredient(API) Product Portfolios and Specifications
Table 125. Biocon Active Pharmaceutical Ingredient(API) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 126. Biocon Main Business
Table 127. Biocon Latest Developments
Table 128. Bristol Myers Squibb Basic Information, Active Pharmaceutical Ingredient(API) Manufacturing Base, Sales Area and Its Competitors
Table 129. Bristol Myers Squibb Active Pharmaceutical Ingredient(API) Product Portfolios and Specifications
Table 130. Bristol Myers Squibb Active Pharmaceutical Ingredient(API) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 131. Bristol Myers Squibb Main Business
Table 132. Bristol Myers Squibb Latest Developments
Table 133. C.H.Boehringer Sohn AG&Co.KG Basic Information, Active Pharmaceutical Ingredient(API) Manufacturing Base, Sales Area and Its Competitors
Table 134. C.H.Boehringer Sohn AG&Co.KG Active Pharmaceutical Ingredient(API) Product Portfolios and Specifications
Table 135. C.H.Boehringer Sohn AG&Co.KG Active Pharmaceutical Ingredient(API) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 136. C.H.Boehringer Sohn AG&Co.KG Main Business
Table 137. C.H.Boehringer Sohn AG&Co.KG Latest Developments
Table 138. Cipla Basic Information, Active Pharmaceutical Ingredient(API) Manufacturing Base, Sales Area and Its Competitors
Table 139. Cipla Active Pharmaceutical Ingredient(API) Product Portfolios and Specifications
Table 140. Cipla Active Pharmaceutical Ingredient(API) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 141. Cipla Main Business
Table 142. Cipla Latest Developments
Table 143. Albemarle Corporation Basic Information, Active Pharmaceutical Ingredient(API) Manufacturing Base, Sales Area and Its Competitors
Table 144. Albemarle Corporation Active Pharmaceutical Ingredient(API) Product Portfolios and Specifications
Table 145. Albemarle Corporation Active Pharmaceutical Ingredient(API) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 146. Albemarle Corporation Main Business
Table 147. Albemarle Corporation Latest Developments
Table 148. Viatris Basic Information, Active Pharmaceutical Ingredient(API) Manufacturing Base, Sales Area and Its Competitors
Table 149. Viatris Active Pharmaceutical Ingredient(API) Product Portfolios and Specifications
Table 150. Viatris Active Pharmaceutical Ingredient(API) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 151. Viatris Main Business
Table 152. Viatris Latest Developments
Table 153. Dr. Reddy's Laboratories Basic Information, Active Pharmaceutical Ingredient(API) Manufacturing Base, Sales Area and Its Competitors
Table 154. Dr. Reddy's Laboratories Active Pharmaceutical Ingredient(API) Product Portfolios and Specifications
Table 155. Dr. Reddy's Laboratories Active Pharmaceutical Ingredient(API) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 156. Dr. Reddy's Laboratories Main Business
Table 157. Dr. Reddy's Laboratories Latest Developments
Table 1. Active Pharmaceutical Ingredient(API) Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Active Pharmaceutical Ingredient(API) Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Generic API
Table 4. Major Players of Innovative API
Table 5. Global Active Pharmaceutical Ingredient(API) Sales by Type (2018-2023) & (K Units)
Table 6. Global Active Pharmaceutical Ingredient(API) Sales Market Share by Type (2018-2023)
Table 7. Global Active Pharmaceutical Ingredient(API) Revenue by Type (2018-2023) & ($ million)
Table 8. Global Active Pharmaceutical Ingredient(API) Revenue Market Share by Type (2018-2023)
Table 9. Global Active Pharmaceutical Ingredient(API) Sale Price by Type (2018-2023) & (US$/Unit)
Table 10. Global Active Pharmaceutical Ingredient(API) Sales by Application (2018-2023) & (K Units)
Table 11. Global Active Pharmaceutical Ingredient(API) Sales Market Share by Application (2018-2023)
Table 12. Global Active Pharmaceutical Ingredient(API) Revenue by Application (2018-2023)
Table 13. Global Active Pharmaceutical Ingredient(API) Revenue Market Share by Application (2018-2023)
Table 14. Global Active Pharmaceutical Ingredient(API) Sale Price by Application (2018-2023) & (US$/Unit)
Table 15. Global Active Pharmaceutical Ingredient(API) Sales by Company (2018-2023) & (K Units)
Table 16. Global Active Pharmaceutical Ingredient(API) Sales Market Share by Company (2018-2023)
Table 17. Global Active Pharmaceutical Ingredient(API) Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Active Pharmaceutical Ingredient(API) Revenue Market Share by Company (2018-2023)
Table 19. Global Active Pharmaceutical Ingredient(API) Sale Price by Company (2018-2023) & (US$/Unit)
Table 20. Key Manufacturers Active Pharmaceutical Ingredient(API) Producing Area Distribution and Sales Area
Table 21. Players Active Pharmaceutical Ingredient(API) Products Offered
Table 22. Active Pharmaceutical Ingredient(API) Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Active Pharmaceutical Ingredient(API) Sales by Geographic Region (2018-2023) & (K Units)
Table 26. Global Active Pharmaceutical Ingredient(API) Sales Market Share Geographic Region (2018-2023)
Table 27. Global Active Pharmaceutical Ingredient(API) Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Active Pharmaceutical Ingredient(API) Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Active Pharmaceutical Ingredient(API) Sales by Country/Region (2018-2023) & (K Units)
Table 30. Global Active Pharmaceutical Ingredient(API) Sales Market Share by Country/Region (2018-2023)
Table 31. Global Active Pharmaceutical Ingredient(API) Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Active Pharmaceutical Ingredient(API) Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Active Pharmaceutical Ingredient(API) Sales by Country (2018-2023) & (K Units)
Table 34. Americas Active Pharmaceutical Ingredient(API) Sales Market Share by Country (2018-2023)
Table 35. Americas Active Pharmaceutical Ingredient(API) Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Active Pharmaceutical Ingredient(API) Revenue Market Share by Country (2018-2023)
Table 37. Americas Active Pharmaceutical Ingredient(API) Sales by Type (2018-2023) & (K Units)
Table 38. Americas Active Pharmaceutical Ingredient(API) Sales by Application (2018-2023) & (K Units)
Table 39. APAC Active Pharmaceutical Ingredient(API) Sales by Region (2018-2023) & (K Units)
Table 40. APAC Active Pharmaceutical Ingredient(API) Sales Market Share by Region (2018-2023)
Table 41. APAC Active Pharmaceutical Ingredient(API) Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Active Pharmaceutical Ingredient(API) Revenue Market Share by Region (2018-2023)
Table 43. APAC Active Pharmaceutical Ingredient(API) Sales by Type (2018-2023) & (K Units)
Table 44. APAC Active Pharmaceutical Ingredient(API) Sales by Application (2018-2023) & (K Units)
Table 45. Europe Active Pharmaceutical Ingredient(API) Sales by Country (2018-2023) & (K Units)
Table 46. Europe Active Pharmaceutical Ingredient(API) Sales Market Share by Country (2018-2023)
Table 47. Europe Active Pharmaceutical Ingredient(API) Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Active Pharmaceutical Ingredient(API) Revenue Market Share by Country (2018-2023)
Table 49. Europe Active Pharmaceutical Ingredient(API) Sales by Type (2018-2023) & (K Units)
Table 50. Europe Active Pharmaceutical Ingredient(API) Sales by Application (2018-2023) & (K Units)
Table 51. Middle East & Africa Active Pharmaceutical Ingredient(API) Sales by Country (2018-2023) & (K Units)
Table 52. Middle East & Africa Active Pharmaceutical Ingredient(API) Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Active Pharmaceutical Ingredient(API) Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Active Pharmaceutical Ingredient(API) Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Active Pharmaceutical Ingredient(API) Sales by Type (2018-2023) & (K Units)
Table 56. Middle East & Africa Active Pharmaceutical Ingredient(API) Sales by Application (2018-2023) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Active Pharmaceutical Ingredient(API)
Table 58. Key Market Challenges & Risks of Active Pharmaceutical Ingredient(API)
Table 59. Key Industry Trends of Active Pharmaceutical Ingredient(API)
Table 60. Active Pharmaceutical Ingredient(API) Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Active Pharmaceutical Ingredient(API) Distributors List
Table 63. Active Pharmaceutical Ingredient(API) Customer List
Table 64. Global Active Pharmaceutical Ingredient(API) Sales Forecast by Region (2024-2029) & (K Units)
Table 65. Global Active Pharmaceutical Ingredient(API) Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Active Pharmaceutical Ingredient(API) Sales Forecast by Country (2024-2029) & (K Units)
Table 67. Americas Active Pharmaceutical Ingredient(API) Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Active Pharmaceutical Ingredient(API) Sales Forecast by Region (2024-2029) & (K Units)
Table 69. APAC Active Pharmaceutical Ingredient(API) Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Active Pharmaceutical Ingredient(API) Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Europe Active Pharmaceutical Ingredient(API) Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Active Pharmaceutical Ingredient(API) Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Middle East & Africa Active Pharmaceutical Ingredient(API) Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Active Pharmaceutical Ingredient(API) Sales Forecast by Type (2024-2029) & (K Units)
Table 75. Global Active Pharmaceutical Ingredient(API) Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Active Pharmaceutical Ingredient(API) Sales Forecast by Application (2024-2029) & (K Units)
Table 77. Global Active Pharmaceutical Ingredient(API) Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Teva Pharmaceuticals Basic Information, Active Pharmaceutical Ingredient(API) Manufacturing Base, Sales Area and Its Competitors
Table 79. Teva Pharmaceuticals Active Pharmaceutical Ingredient(API) Product Portfolios and Specifications
Table 80. Teva Pharmaceuticals Active Pharmaceutical Ingredient(API) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 81. Teva Pharmaceuticals Main Business
Table 82. Teva Pharmaceuticals Latest Developments
Table 83. Pfizer Basic Information, Active Pharmaceutical Ingredient(API) Manufacturing Base, Sales Area and Its Competitors
Table 84. Pfizer Active Pharmaceutical Ingredient(API) Product Portfolios and Specifications
Table 85. Pfizer Active Pharmaceutical Ingredient(API) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 86. Pfizer Main Business
Table 87. Pfizer Latest Developments
Table 88. Aurobindo Pharma Basic Information, Active Pharmaceutical Ingredient(API) Manufacturing Base, Sales Area and Its Competitors
Table 89. Aurobindo Pharma Active Pharmaceutical Ingredient(API) Product Portfolios and Specifications
Table 90. Aurobindo Pharma Active Pharmaceutical Ingredient(API) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 91. Aurobindo Pharma Main Business
Table 92. Aurobindo Pharma Latest Developments
Table 93. Sun Pharmaceutical Industries Ltd. Basic Information, Active Pharmaceutical Ingredient(API) Manufacturing Base, Sales Area and Its Competitors
Table 94. Sun Pharmaceutical Industries Ltd. Active Pharmaceutical Ingredient(API) Product Portfolios and Specifications
Table 95. Sun Pharmaceutical Industries Ltd. Active Pharmaceutical Ingredient(API) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 96. Sun Pharmaceutical Industries Ltd. Main Business
Table 97. Sun Pharmaceutical Industries Ltd. Latest Developments
Table 98. Novartis Basic Information, Active Pharmaceutical Ingredient(API) Manufacturing Base, Sales Area and Its Competitors
Table 99. Novartis Active Pharmaceutical Ingredient(API) Product Portfolios and Specifications
Table 100. Novartis Active Pharmaceutical Ingredient(API) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 101. Novartis Main Business
Table 102. Novartis Latest Developments
Table 103. Mylan Basic Information, Active Pharmaceutical Ingredient(API) Manufacturing Base, Sales Area and Its Competitors
Table 104. Mylan Active Pharmaceutical Ingredient(API) Product Portfolios and Specifications
Table 105. Mylan Active Pharmaceutical Ingredient(API) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 106. Mylan Main Business
Table 107. Mylan Latest Developments
Table 108. Boehringer Ingelheim Basic Information, Active Pharmaceutical Ingredient(API) Manufacturing Base, Sales Area and Its Competitors
Table 109. Boehringer Ingelheim Active Pharmaceutical Ingredient(API) Product Portfolios and Specifications
Table 110. Boehringer Ingelheim Active Pharmaceutical Ingredient(API) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 111. Boehringer Ingelheim Main Business
Table 112. Boehringer Ingelheim Latest Developments
Table 113. Merck&Co. Basic Information, Active Pharmaceutical Ingredient(API) Manufacturing Base, Sales Area and Its Competitors
Table 114. Merck&Co. Active Pharmaceutical Ingredient(API) Product Portfolios and Specifications
Table 115. Merck&Co. Active Pharmaceutical Ingredient(API) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 116. Merck&Co. Main Business
Table 117. Merck&Co. Latest Developments
Table 118. AbbVie Basic Information, Active Pharmaceutical Ingredient(API) Manufacturing Base, Sales Area and Its Competitors
Table 119. AbbVie Active Pharmaceutical Ingredient(API) Product Portfolios and Specifications
Table 120. AbbVie Active Pharmaceutical Ingredient(API) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 121. AbbVie Main Business
Table 122. AbbVie Latest Developments
Table 123. Biocon Basic Information, Active Pharmaceutical Ingredient(API) Manufacturing Base, Sales Area and Its Competitors
Table 124. Biocon Active Pharmaceutical Ingredient(API) Product Portfolios and Specifications
Table 125. Biocon Active Pharmaceutical Ingredient(API) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 126. Biocon Main Business
Table 127. Biocon Latest Developments
Table 128. Bristol Myers Squibb Basic Information, Active Pharmaceutical Ingredient(API) Manufacturing Base, Sales Area and Its Competitors
Table 129. Bristol Myers Squibb Active Pharmaceutical Ingredient(API) Product Portfolios and Specifications
Table 130. Bristol Myers Squibb Active Pharmaceutical Ingredient(API) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 131. Bristol Myers Squibb Main Business
Table 132. Bristol Myers Squibb Latest Developments
Table 133. C.H.Boehringer Sohn AG&Co.KG Basic Information, Active Pharmaceutical Ingredient(API) Manufacturing Base, Sales Area and Its Competitors
Table 134. C.H.Boehringer Sohn AG&Co.KG Active Pharmaceutical Ingredient(API) Product Portfolios and Specifications
Table 135. C.H.Boehringer Sohn AG&Co.KG Active Pharmaceutical Ingredient(API) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 136. C.H.Boehringer Sohn AG&Co.KG Main Business
Table 137. C.H.Boehringer Sohn AG&Co.KG Latest Developments
Table 138. Cipla Basic Information, Active Pharmaceutical Ingredient(API) Manufacturing Base, Sales Area and Its Competitors
Table 139. Cipla Active Pharmaceutical Ingredient(API) Product Portfolios and Specifications
Table 140. Cipla Active Pharmaceutical Ingredient(API) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 141. Cipla Main Business
Table 142. Cipla Latest Developments
Table 143. Albemarle Corporation Basic Information, Active Pharmaceutical Ingredient(API) Manufacturing Base, Sales Area and Its Competitors
Table 144. Albemarle Corporation Active Pharmaceutical Ingredient(API) Product Portfolios and Specifications
Table 145. Albemarle Corporation Active Pharmaceutical Ingredient(API) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 146. Albemarle Corporation Main Business
Table 147. Albemarle Corporation Latest Developments
Table 148. Viatris Basic Information, Active Pharmaceutical Ingredient(API) Manufacturing Base, Sales Area and Its Competitors
Table 149. Viatris Active Pharmaceutical Ingredient(API) Product Portfolios and Specifications
Table 150. Viatris Active Pharmaceutical Ingredient(API) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 151. Viatris Main Business
Table 152. Viatris Latest Developments
Table 153. Dr. Reddy's Laboratories Basic Information, Active Pharmaceutical Ingredient(API) Manufacturing Base, Sales Area and Its Competitors
Table 154. Dr. Reddy's Laboratories Active Pharmaceutical Ingredient(API) Product Portfolios and Specifications
Table 155. Dr. Reddy's Laboratories Active Pharmaceutical Ingredient(API) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 156. Dr. Reddy's Laboratories Main Business
Table 157. Dr. Reddy's Laboratories Latest Developments
LIST OF FIGURES
Figure 1. Picture of Active Pharmaceutical Ingredient(API)
Figure 2. Active Pharmaceutical Ingredient(API) Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Active Pharmaceutical Ingredient(API) Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Active Pharmaceutical Ingredient(API) Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Active Pharmaceutical Ingredient(API) Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Generic API
Figure 10. Product Picture of Innovative API
Figure 11. Global Active Pharmaceutical Ingredient(API) Sales Market Share by Type in 2022
Figure 12. Global Active Pharmaceutical Ingredient(API) Revenue Market Share by Type (2018-2023)
Figure 13. Active Pharmaceutical Ingredient(API) Consumed in Oncology
Figure 14. Global Active Pharmaceutical Ingredient(API) Market: Oncology (2018-2023) & (K Units)
Figure 15. Active Pharmaceutical Ingredient(API) Consumed in Cardiology
Figure 16. Global Active Pharmaceutical Ingredient(API) Market: Cardiology (2018-2023) & (K Units)
Figure 17. Active Pharmaceutical Ingredient(API) Consumed in Cns and Neurology
Figure 18. Global Active Pharmaceutical Ingredient(API) Market: Cns and Neurology (2018-2023) & (K Units)
Figure 19. Active Pharmaceutical Ingredient(API) Consumed in Orthopaedic
Figure 20. Global Active Pharmaceutical Ingredient(API) Market: Orthopaedic (2018-2023) & (K Units)
Figure 21. Active Pharmaceutical Ingredient(API) Consumed in Pulmonology
Figure 22. Global Active Pharmaceutical Ingredient(API) Market: Pulmonology (2018-2023) & (K Units)
Figure 23. Active Pharmaceutical Ingredient(API) Consumed in Gastroenterology
Figure 24. Global Active Pharmaceutical Ingredient(API) Market: Gastroenterology (2018-2023) & (K Units)
Figure 25. Active Pharmaceutical Ingredient(API) Consumed in Nephrology
Figure 26. Global Active Pharmaceutical Ingredient(API) Market: Nephrology (2018-2023) & (K Units)
Figure 27. Active Pharmaceutical Ingredient(API) Consumed in Ophthalmology
Figure 28. Global Active Pharmaceutical Ingredient(API) Market: Ophthalmology (2018-2023) & (K Units)
Figure 29. Active Pharmaceutical Ingredient(API) Consumed in Endocrinology
Figure 30. Global Active Pharmaceutical Ingredient(API) Market: Endocrinology (2018-2023) & (K Units)
Figure 31. Global Active Pharmaceutical Ingredient(API) Sales Market Share by Application (2022)
Figure 32. Global Active Pharmaceutical Ingredient(API) Revenue Market Share by Application in 2022
Figure 33. Active Pharmaceutical Ingredient(API) Sales Market by Company in 2022 (K Units)
Figure 34. Global Active Pharmaceutical Ingredient(API) Sales Market Share by Company in 2022
Figure 35. Active Pharmaceutical Ingredient(API) Revenue Market by Company in 2022 ($ Million)
Figure 36. Global Active Pharmaceutical Ingredient(API) Revenue Market Share by Company in 2022
Figure 37. Global Active Pharmaceutical Ingredient(API) Sales Market Share by Geographic Region (2018-2023)
Figure 38. Global Active Pharmaceutical Ingredient(API) Revenue Market Share by Geographic Region in 2022
Figure 39. Americas Active Pharmaceutical Ingredient(API) Sales 2018-2023 (K Units)
Figure 40. Americas Active Pharmaceutical Ingredient(API) Revenue 2018-2023 ($ Millions)
Figure 41. APAC Active Pharmaceutical Ingredient(API) Sales 2018-2023 (K Units)
Figure 42. APAC Active Pharmaceutical Ingredient(API) Revenue 2018-2023 ($ Millions)
Figure 43. Europe Active Pharmaceutical Ingredient(API) Sales 2018-2023 (K Units)
Figure 44. Europe Active Pharmaceutical Ingredient(API) Revenue 2018-2023 ($ Millions)
Figure 45. Middle East & Africa Active Pharmaceutical Ingredient(API) Sales 2018-2023 (K Units)
Figure 46. Middle East & Africa Active Pharmaceutical Ingredient(API) Revenue 2018-2023 ($ Millions)
Figure 47. Americas Active Pharmaceutical Ingredient(API) Sales Market Share by Country in 2022
Figure 48. Americas Active Pharmaceutical Ingredient(API) Revenue Market Share by Country in 2022
Figure 49. Americas Active Pharmaceutical Ingredient(API) Sales Market Share by Type (2018-2023)
Figure 50. Americas Active Pharmaceutical Ingredient(API) Sales Market Share by Application (2018-2023)
Figure 51. United States Active Pharmaceutical Ingredient(API) Revenue Growth 2018-2023 ($ Millions)
Figure 52. Canada Active Pharmaceutical Ingredient(API) Revenue Growth 2018-2023 ($ Millions)
Figure 53. Mexico Active Pharmaceutical Ingredient(API) Revenue Growth 2018-2023 ($ Millions)
Figure 54. Brazil Active Pharmaceutical Ingredient(API) Revenue Growth 2018-2023 ($ Millions)
Figure 55. APAC Active Pharmaceutical Ingredient(API) Sales Market Share by Region in 2022
Figure 56. APAC Active Pharmaceutical Ingredient(API) Revenue Market Share by Regions in 2022
Figure 57. APAC Active Pharmaceutical Ingredient(API) Sales Market Share by Type (2018-2023)
Figure 58. APAC Active Pharmaceutical Ingredient(API) Sales Market Share by Application (2018-2023)
Figure 59. China Active Pharmaceutical Ingredient(API) Revenue Growth 2018-2023 ($ Millions)
Figure 60. Japan Active Pharmaceutical Ingredient(API) Revenue Growth 2018-2023 ($ Millions)
Figure 61. South Korea Active Pharmaceutical Ingredient(API) Revenue Growth 2018-2023 ($ Millions)
Figure 62. Southeast Asia Active Pharmaceutical Ingredient(API) Revenue Growth 2018-2023 ($ Millions)
Figure 63. India Active Pharmaceutical Ingredient(API) Revenue Growth 2018-2023 ($ Millions)
Figure 64. Australia Active Pharmaceutical Ingredient(API) Revenue Growth 2018-2023 ($ Millions)
Figure 65. China Taiwan Active Pharmaceutical Ingredient(API) Revenue Growth 2018-2023 ($ Millions)
Figure 66. Europe Active Pharmaceutical Ingredient(API) Sales Market Share by Country in 2022
Figure 67. Europe Active Pharmaceutical Ingredient(API) Revenue Market Share by Country in 2022
Figure 68. Europe Active Pharmaceutical Ingredient(API) Sales Market Share by Type (2018-2023)
Figure 69. Europe Active Pharmaceutical Ingredient(API) Sales Market Share by Application (2018-2023)
Figure 70. Germany Active Pharmaceutical Ingredient(API) Revenue Growth 2018-2023 ($ Millions)
Figure 71. France Active Pharmaceutical Ingredient(API) Revenue Growth 2018-2023 ($ Millions)
Figure 72. UK Active Pharmaceutical Ingredient(API) Revenue Growth 2018-2023 ($ Millions)
Figure 73. Italy Active Pharmaceutical Ingredient(API) Revenue Growth 2018-2023 ($ Millions)
Figure 74. Russia Active Pharmaceutical Ingredient(API) Revenue Growth 2018-2023 ($ Millions)
Figure 75. Middle East & Africa Active Pharmaceutical Ingredient(API) Sales Market Share by Country in 2022
Figure 76. Middle East & Africa Active Pharmaceutical Ingredient(API) Revenue Market Share by Country in 2022
Figure 77. Middle East & Africa Active Pharmaceutical Ingredient(API) Sales Market Share by Type (2018-2023)
Figure 78. Middle East & Africa Active Pharmaceutical Ingredient(API) Sales Market Share by Application (2018-2023)
Figure 79. Egypt Active Pharmaceutical Ingredient(API) Revenue Growth 2018-2023 ($ Millions)
Figure 80. South Africa Active Pharmaceutical Ingredient(API) Revenue Growth 2018-2023 ($ Millions)
Figure 81. Israel Active Pharmaceutical Ingredient(API) Revenue Growth 2018-2023 ($ Millions)
Figure 82. Turkey Active Pharmaceutical Ingredient(API) Revenue Growth 2018-2023 ($ Millions)
Figure 83. GCC Country Active Pharmaceutical Ingredient(API) Revenue Growth 2018-2023 ($ Millions)
Figure 84. Manufacturing Cost Structure Analysis of Active Pharmaceutical Ingredient(API) in 2022
Figure 85. Manufacturing Process Analysis of Active Pharmaceutical Ingredient(API)
Figure 86. Industry Chain Structure of Active Pharmaceutical Ingredient(API)
Figure 87. Channels of Distribution
Figure 88. Global Active Pharmaceutical Ingredient(API) Sales Market Forecast by Region (2024-2029)
Figure 89. Global Active Pharmaceutical Ingredient(API) Revenue Market Share Forecast by Region (2024-2029)
Figure 90. Global Active Pharmaceutical Ingredient(API) Sales Market Share Forecast by Type (2024-2029)
Figure 91. Global Active Pharmaceutical Ingredient(API) Revenue Market Share Forecast by Type (2024-2029)
Figure 92. Global Active Pharmaceutical Ingredient(API) Sales Market Share Forecast by Application (2024-2029)
Figure 93. Global Active Pharmaceutical Ingredient(API) Revenue Market Share Forecast by Application (2024-2029)
Figure 1. Picture of Active Pharmaceutical Ingredient(API)
Figure 2. Active Pharmaceutical Ingredient(API) Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Active Pharmaceutical Ingredient(API) Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Active Pharmaceutical Ingredient(API) Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Active Pharmaceutical Ingredient(API) Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Generic API
Figure 10. Product Picture of Innovative API
Figure 11. Global Active Pharmaceutical Ingredient(API) Sales Market Share by Type in 2022
Figure 12. Global Active Pharmaceutical Ingredient(API) Revenue Market Share by Type (2018-2023)
Figure 13. Active Pharmaceutical Ingredient(API) Consumed in Oncology
Figure 14. Global Active Pharmaceutical Ingredient(API) Market: Oncology (2018-2023) & (K Units)
Figure 15. Active Pharmaceutical Ingredient(API) Consumed in Cardiology
Figure 16. Global Active Pharmaceutical Ingredient(API) Market: Cardiology (2018-2023) & (K Units)
Figure 17. Active Pharmaceutical Ingredient(API) Consumed in Cns and Neurology
Figure 18. Global Active Pharmaceutical Ingredient(API) Market: Cns and Neurology (2018-2023) & (K Units)
Figure 19. Active Pharmaceutical Ingredient(API) Consumed in Orthopaedic
Figure 20. Global Active Pharmaceutical Ingredient(API) Market: Orthopaedic (2018-2023) & (K Units)
Figure 21. Active Pharmaceutical Ingredient(API) Consumed in Pulmonology
Figure 22. Global Active Pharmaceutical Ingredient(API) Market: Pulmonology (2018-2023) & (K Units)
Figure 23. Active Pharmaceutical Ingredient(API) Consumed in Gastroenterology
Figure 24. Global Active Pharmaceutical Ingredient(API) Market: Gastroenterology (2018-2023) & (K Units)
Figure 25. Active Pharmaceutical Ingredient(API) Consumed in Nephrology
Figure 26. Global Active Pharmaceutical Ingredient(API) Market: Nephrology (2018-2023) & (K Units)
Figure 27. Active Pharmaceutical Ingredient(API) Consumed in Ophthalmology
Figure 28. Global Active Pharmaceutical Ingredient(API) Market: Ophthalmology (2018-2023) & (K Units)
Figure 29. Active Pharmaceutical Ingredient(API) Consumed in Endocrinology
Figure 30. Global Active Pharmaceutical Ingredient(API) Market: Endocrinology (2018-2023) & (K Units)
Figure 31. Global Active Pharmaceutical Ingredient(API) Sales Market Share by Application (2022)
Figure 32. Global Active Pharmaceutical Ingredient(API) Revenue Market Share by Application in 2022
Figure 33. Active Pharmaceutical Ingredient(API) Sales Market by Company in 2022 (K Units)
Figure 34. Global Active Pharmaceutical Ingredient(API) Sales Market Share by Company in 2022
Figure 35. Active Pharmaceutical Ingredient(API) Revenue Market by Company in 2022 ($ Million)
Figure 36. Global Active Pharmaceutical Ingredient(API) Revenue Market Share by Company in 2022
Figure 37. Global Active Pharmaceutical Ingredient(API) Sales Market Share by Geographic Region (2018-2023)
Figure 38. Global Active Pharmaceutical Ingredient(API) Revenue Market Share by Geographic Region in 2022
Figure 39. Americas Active Pharmaceutical Ingredient(API) Sales 2018-2023 (K Units)
Figure 40. Americas Active Pharmaceutical Ingredient(API) Revenue 2018-2023 ($ Millions)
Figure 41. APAC Active Pharmaceutical Ingredient(API) Sales 2018-2023 (K Units)
Figure 42. APAC Active Pharmaceutical Ingredient(API) Revenue 2018-2023 ($ Millions)
Figure 43. Europe Active Pharmaceutical Ingredient(API) Sales 2018-2023 (K Units)
Figure 44. Europe Active Pharmaceutical Ingredient(API) Revenue 2018-2023 ($ Millions)
Figure 45. Middle East & Africa Active Pharmaceutical Ingredient(API) Sales 2018-2023 (K Units)
Figure 46. Middle East & Africa Active Pharmaceutical Ingredient(API) Revenue 2018-2023 ($ Millions)
Figure 47. Americas Active Pharmaceutical Ingredient(API) Sales Market Share by Country in 2022
Figure 48. Americas Active Pharmaceutical Ingredient(API) Revenue Market Share by Country in 2022
Figure 49. Americas Active Pharmaceutical Ingredient(API) Sales Market Share by Type (2018-2023)
Figure 50. Americas Active Pharmaceutical Ingredient(API) Sales Market Share by Application (2018-2023)
Figure 51. United States Active Pharmaceutical Ingredient(API) Revenue Growth 2018-2023 ($ Millions)
Figure 52. Canada Active Pharmaceutical Ingredient(API) Revenue Growth 2018-2023 ($ Millions)
Figure 53. Mexico Active Pharmaceutical Ingredient(API) Revenue Growth 2018-2023 ($ Millions)
Figure 54. Brazil Active Pharmaceutical Ingredient(API) Revenue Growth 2018-2023 ($ Millions)
Figure 55. APAC Active Pharmaceutical Ingredient(API) Sales Market Share by Region in 2022
Figure 56. APAC Active Pharmaceutical Ingredient(API) Revenue Market Share by Regions in 2022
Figure 57. APAC Active Pharmaceutical Ingredient(API) Sales Market Share by Type (2018-2023)
Figure 58. APAC Active Pharmaceutical Ingredient(API) Sales Market Share by Application (2018-2023)
Figure 59. China Active Pharmaceutical Ingredient(API) Revenue Growth 2018-2023 ($ Millions)
Figure 60. Japan Active Pharmaceutical Ingredient(API) Revenue Growth 2018-2023 ($ Millions)
Figure 61. South Korea Active Pharmaceutical Ingredient(API) Revenue Growth 2018-2023 ($ Millions)
Figure 62. Southeast Asia Active Pharmaceutical Ingredient(API) Revenue Growth 2018-2023 ($ Millions)
Figure 63. India Active Pharmaceutical Ingredient(API) Revenue Growth 2018-2023 ($ Millions)
Figure 64. Australia Active Pharmaceutical Ingredient(API) Revenue Growth 2018-2023 ($ Millions)
Figure 65. China Taiwan Active Pharmaceutical Ingredient(API) Revenue Growth 2018-2023 ($ Millions)
Figure 66. Europe Active Pharmaceutical Ingredient(API) Sales Market Share by Country in 2022
Figure 67. Europe Active Pharmaceutical Ingredient(API) Revenue Market Share by Country in 2022
Figure 68. Europe Active Pharmaceutical Ingredient(API) Sales Market Share by Type (2018-2023)
Figure 69. Europe Active Pharmaceutical Ingredient(API) Sales Market Share by Application (2018-2023)
Figure 70. Germany Active Pharmaceutical Ingredient(API) Revenue Growth 2018-2023 ($ Millions)
Figure 71. France Active Pharmaceutical Ingredient(API) Revenue Growth 2018-2023 ($ Millions)
Figure 72. UK Active Pharmaceutical Ingredient(API) Revenue Growth 2018-2023 ($ Millions)
Figure 73. Italy Active Pharmaceutical Ingredient(API) Revenue Growth 2018-2023 ($ Millions)
Figure 74. Russia Active Pharmaceutical Ingredient(API) Revenue Growth 2018-2023 ($ Millions)
Figure 75. Middle East & Africa Active Pharmaceutical Ingredient(API) Sales Market Share by Country in 2022
Figure 76. Middle East & Africa Active Pharmaceutical Ingredient(API) Revenue Market Share by Country in 2022
Figure 77. Middle East & Africa Active Pharmaceutical Ingredient(API) Sales Market Share by Type (2018-2023)
Figure 78. Middle East & Africa Active Pharmaceutical Ingredient(API) Sales Market Share by Application (2018-2023)
Figure 79. Egypt Active Pharmaceutical Ingredient(API) Revenue Growth 2018-2023 ($ Millions)
Figure 80. South Africa Active Pharmaceutical Ingredient(API) Revenue Growth 2018-2023 ($ Millions)
Figure 81. Israel Active Pharmaceutical Ingredient(API) Revenue Growth 2018-2023 ($ Millions)
Figure 82. Turkey Active Pharmaceutical Ingredient(API) Revenue Growth 2018-2023 ($ Millions)
Figure 83. GCC Country Active Pharmaceutical Ingredient(API) Revenue Growth 2018-2023 ($ Millions)
Figure 84. Manufacturing Cost Structure Analysis of Active Pharmaceutical Ingredient(API) in 2022
Figure 85. Manufacturing Process Analysis of Active Pharmaceutical Ingredient(API)
Figure 86. Industry Chain Structure of Active Pharmaceutical Ingredient(API)
Figure 87. Channels of Distribution
Figure 88. Global Active Pharmaceutical Ingredient(API) Sales Market Forecast by Region (2024-2029)
Figure 89. Global Active Pharmaceutical Ingredient(API) Revenue Market Share Forecast by Region (2024-2029)
Figure 90. Global Active Pharmaceutical Ingredient(API) Sales Market Share Forecast by Type (2024-2029)
Figure 91. Global Active Pharmaceutical Ingredient(API) Revenue Market Share Forecast by Type (2024-2029)
Figure 92. Global Active Pharmaceutical Ingredient(API) Sales Market Share Forecast by Application (2024-2029)
Figure 93. Global Active Pharmaceutical Ingredient(API) Revenue Market Share Forecast by Application (2024-2029)
